393 related articles for article (PubMed ID: 11248079)
1. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.
Reiman EM; Caselli RJ; Chen K; Alexander GE; Bandy D; Frost J
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3334-9. PubMed ID: 11248079
[TBL] [Abstract][Full Text] [Related]
2. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
[TBL] [Abstract][Full Text] [Related]
3. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8299-302. PubMed ID: 15932949
[TBL] [Abstract][Full Text] [Related]
4. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):284-9. PubMed ID: 14688411
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
[TBL] [Abstract][Full Text] [Related]
6. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
7. Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.
Nielsen HM; Chen K; Lee W; Chen Y; Bauer RJ; Reiman E; Caselli R; Bu G
Alzheimers Res Ther; 2017 Jan; 9(1):5. PubMed ID: 28137305
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
9. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ
Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758
[TBL] [Abstract][Full Text] [Related]
10. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
Mielke R; Zerres K; Uhlhaas S; Kessler J; Heiss WD
Neurosci Lett; 1998 Sep; 254(1):49-52. PubMed ID: 9780089
[TBL] [Abstract][Full Text] [Related]
12. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
13. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism and gray-matter concentration in apolipoprotein E ε4 positive normal subjects.
Samuraki M; Matsunari I; Chen WP; Shima K; Yanase D; Takeda N; Matsuda H; Yamada M
Neurobiol Aging; 2012 Oct; 33(10):2321-3. PubMed ID: 22188720
[TBL] [Abstract][Full Text] [Related]
15. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers.
Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L
Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568
[TBL] [Abstract][Full Text] [Related]
16. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G
J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316
[TBL] [Abstract][Full Text] [Related]
17. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.
Protas HD; Chen K; Langbaum JB; Fleisher AS; Alexander GE; Lee W; Bandy D; de Leon MJ; Mosconi L; Buckley S; Truran-Sacrey D; Schuff N; Weiner MW; Caselli RJ; Reiman EM
JAMA Neurol; 2013 Mar; 70(3):320-5. PubMed ID: 23599929
[TBL] [Abstract][Full Text] [Related]
18. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
Pardo JV; Lee JT;
eNeuro; 2018; 5(1):. PubMed ID: 29497704
[TBL] [Abstract][Full Text] [Related]
19. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
Reiman EM; Chen K; Liu X; Bandy D; Yu M; Lee W; Ayutyanont N; Keppler J; Reeder SA; Langbaum JB; Alexander GE; Klunk WE; Mathis CA; Price JC; Aizenstein HJ; DeKosky ST; Caselli RJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6820-5. PubMed ID: 19346482
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.
Reiman EM; Uecker A; Caselli RJ; Lewis S; Bandy D; de Leon MJ; De Santi S; Convit A; Osborne D; Weaver A; Thibodeau SN
Ann Neurol; 1998 Aug; 44(2):288-91. PubMed ID: 9708558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
